weight loss, compounding and Food and Drug Administration

Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US, according to the US Food and Drug Administration (FDA). That means that compounding pharmacies and outsourcing facilities that had been legitimately preparing their own versions of the drugs will no longer be permitted to do so.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for weight loss, as is permissible by the FDA.
Who can get weight loss drugs on the NHS in Scotland?
The medicines watchdog has agreed the drugs are safe and cost-effective for NHS use. Last year, semaglutide was approved for treating obesity under the brand name Wegovy. It has also been licensed under the brand name Ozempic for treating diabetes in some circumstances,
Compound versions of weight loss drugs will no longer be available, FDA rules
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available after a decision by the U.S. Food and Drug Administration. The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply.
Managed Healthcare Executive2h
FDA Approves First Generics of Xarelto
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...
CNET on MSN5d
Natural Medicine vs. FDA Drugs: Which Should You Use for Your Ailment?
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
The Cardiology Advisor2d
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Will Trump Drug Tariffs Help Or Hurt The U.S.?
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
MyChesCo on MSN2d
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings
The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...
AOL4d
How a new FDA-approved drug can — and can’t — help people with Alzheimer’s
If you have a loved one with Alzheimer’s disease, you may have read about a newly approved drug. And you may have heard that the drug has caused some controversy. So, what’s really going on?
Medscape6d
As Trump Administration Probes Long-Approved Medications, Could FDA Revoke Approvals?
A new federal commission will ‘investigate’ decades-old mental health as well as weight loss drugs, prompting concerns from ...
EL PAÍS English7h
The most expensive drug ever approved: A gene therapy that cures butterfly skin and could cost $20 million per patient
Mía had dystrophic epidermolysis bullosa, better known as butterfly skin due to the extreme fragility of this tissue in ...
News-Medical.Net5h
How consultants help accelerate drug product development timelines
Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.
Medscape5d
How Many Patients in Early Cancer Trials Get Drugs Ultimately Approved by FDA?
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
PharmExec1d
FDA’s New Accelerated Approval Draft Guidance
The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...